Galactose-Functionalized Gold Nanoparticles Targeting Membrane Transporters for the Glutathione Delivery to Brain...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Neuroscience

Background:

• Glutathione (GSH) is crucial for cellular redox balance and protecting against oxidative stress.
• GSH deficiency is linked to oxidative damage and diseases like cancer and neurological disorders.
• Overexpression of glucose transporters (GLUT) on the blood-brain barrier (BBB) presents a therapeutic targeting opportunity.

Purpose of the Study:

• To develop gold nanoparticles (Au NPs) functionalized with GSH and galactose for targeted delivery across the BBB.
• To investigate the selective targeting and internalization of these nanoparticles by GLUT-overexpressing cells.
• To evaluate the antioxidant efficacy of the functionalized nanoparticles in reducing oxidative stress.

Main Methods:

• Synthesis of GSH-coated and galactose-functionalized gold nanoparticles (Au@GSH-Gal NPs).
• Characterization of nanoparticle properties and targeting capabilities.
• In vitro testing on brain cancer cells to assess internalization and H2O2-induced oxidative stress reduction.

Main Results:

• Au@GSH-Gal NPs demonstrated selective targeting and enhanced internalization in brain cancer cells.
• Treatment with Au@GSH-Gal NPs significantly reduced hydrogen peroxide (H2O2)-induced oxidative stress.
• The study provides proof of concept for BBB-targeted antioxidant delivery.

Conclusions:

• Functionalized gold nanoparticles show promise for targeted antioxidant therapy in neurological diseases.
• Exploiting GLUT on the BBB offers a viable strategy for drug delivery to the brain.
• Au@GSH-Gal NPs represent a novel approach to combat oxidative stress in brain pathologies.